Full Press Release Details
Solid Biosciences Reports Positive Initial Clinical Data from Next Generation Duchenne Gene Therapy Candidate SGT-003.
SLDB
Solid Biosciences Reports Positive Initial Clinical Data from Next Generation Duchenne Gene Therapy Candidate SGT-003
Key Takeaway: Solid Biosciences Reports Positive Initial Clinical Data from Next Generation Duchenne Gene Therapy Candidate SGT-003